Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 8
2004 9
2005 14
2006 9
2007 10
2008 16
2009 11
2010 17
2011 17
2012 21
2013 22
2014 28
2015 32
2016 38
2017 32
2018 35
2019 45
2020 57
2021 50
2022 59
2023 53
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

515 results

Results by year

Filters applied: . Clear all
Page 1
High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer.
Mizuno S, Ikegami M, Koyama T, Sunami K, Ogata D, Kage H, Yanagaki M, Ikeuchi H, Ueno T, Tanikawa M, Oda K, Osuga Y, Mano H, Kohsaka S. Mizuno S, et al. Among authors: osuga y. Mol Cancer Ther. 2023 Feb 1;22(2):227-239. doi: 10.1158/1535-7163.MCT-22-0302. Mol Cancer Ther. 2023. PMID: 36442478 Free PMC article.
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study.
Harada T, Osuga Y, Suzuki Y, Fujisawa M, Fukui M, Kitawaki J. Harada T, et al. Among authors: osuga y. Fertil Steril. 2022 Mar;117(3):583-592. doi: 10.1016/j.fertnstert.2021.11.013. Epub 2021 Dec 8. Fertil Steril. 2022. PMID: 34895700 Free article. Clinical Trial.
Lymphocytes in endometriosis.
Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Osuga Y, et al. Am J Reprod Immunol. 2011 Jan;65(1):1-10. doi: 10.1111/j.1600-0897.2010.00887.x. Am J Reprod Immunol. 2011. PMID: 20584009 Review.
Guidelines for Reproductive Medicine in Japan.
Yamada M, Ishikawa T, Iwasa T, Oishi H, Osuka S, Oka K, Ono S, Ono M, Orisaka M, Kanasaki H, Kawano Y, Kawamura K, Kishi H, Kimura F, Kuroda S, Kuwahara A, Kobayashi H, Komiya A, Saito H, Sato K, Sato S, Shiraishi K, Shirasawa H, Suzuki T, Takai Y, Takae S, Takahashi T, Takiuchi T, Tachibana M, Tamura I, Tamura H, Jwa SC, Baba T, Harada M, Hirata T, Fukui A, Fukuda Y, Fukuhara S, Maruyama T, Yumura Y, Yoshino O, Hirota Y, Tsujimura A, Kuji N, Osuga Y. Yamada M, et al. Among authors: osuga y. Reprod Med Biol. 2022 Aug 24;21(1):e12483. doi: 10.1002/rmb2.12483. eCollection 2022 Jan-Dec. Reprod Med Biol. 2022. PMID: 36033549 Free PMC article. No abstract available.
Role of adenosine signaling in preeclampsia.
Iriyama T, Sayama S, Osuga Y. Iriyama T, et al. Among authors: osuga y. J Obstet Gynaecol Res. 2022 Jan;48(1):49-57. doi: 10.1111/jog.15066. Epub 2021 Oct 17. J Obstet Gynaecol Res. 2022. PMID: 34657345 Review.
Management of the female athlete triad.
Nose-Ogura S, Harada M, Hiraike O, Osuga Y, Fujii T. Nose-Ogura S, et al. Among authors: osuga y. J Obstet Gynaecol Res. 2018 Jun;44(6):1007-1014. doi: 10.1111/jog.13614. Epub 2018 Apr 2. J Obstet Gynaecol Res. 2018. PMID: 29607594 Review.
Fertility preservation for female cancer patients.
Harada M, Osuga Y. Harada M, et al. Among authors: osuga y. Int J Clin Oncol. 2019 Jan;24(1):28-33. doi: 10.1007/s10147-018-1252-0. Epub 2018 Mar 3. Int J Clin Oncol. 2019. PMID: 29502284 Review.
515 results